Men's

Guidelines (12)

Men's in the News

News in brief - January 2015 (updated)

News in brief - January 2015 (updated)

Other new launches, licence changes and updates relevant...

Xtandi: oral anti-androgen for metastatic prostate cancer

Xtandi: oral anti-androgen for metastatic prostate cancer

Xtandi (enzalutamide) is an anti-androgen licensed...

Zytiga approved for use before chemotherapy

Zytiga approved for use before chemotherapy

The licence for Zytiga (abiraterone) has been extended...